Author(s)

Xiaolong Liang ¹, Lushan Zhao ², Xianyou Wang ¹, Yani Fang ¹, Fangliang Chen ¹, Xiaoping Pang ¹

Affiliation(s)

¹ Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang, China
² Hangzhou Medical College, Hangzhou, Zhejiang, China

Corresponding Author

Xiaolong Liang

ABSTRACT

The purpose of this study was to observe the clinical effect and safety of huangʼe capsule on the improvement of symptoms after surgery for benign prostatic hyperplasia. We used random sampling to divide 14 patients with benign prostatic hyperplasia into the experimental group and the control group, with 7 cases in each group. The experimental group was given 4 capsules each time, 3 times a day for 42 days after surgery, while the control group did not receive the treatment of huangʼe capsules. The International Prostatic Hyperplasia Symptom Score (I-PSS), Maximal Uroflow Rate Change (Qmax), Quality of Life Score (QOL) and liver and kidney function indexes were observed in the two groups before and after surgery. The results shows that the postoperative I-PSS, Qmax and QOL of the two groups were significantly improved (P<0.05), while the efficacy of the experimental group was better (P<0.05). The liver and kidney function indexes of the experimental group before and after treatment were within the normal range. It was concluded that Huangʼe capsule could effectively improve the postoperative clinical efficacy of patients with prostatic hyperplasia and had good safety.

KEYWORDS

Huangʼe capsules, prostatic hyperplasia, clinical efficacy, safety

CITE THIS PAPER

Xiaolong Liang, Lushan Zhao, Xianyou Wang, Yani Fang, Fangliang Chen, Xiaoping Pang, Clinical application of huang'e capsule after surgery for prostatic hyperplasia. MEDS Clinical Medicine (2024) Vol. 5: 89-94. DOI: http://dx.doi.org/10.23977/medsc.2024.050214.

REFERENCES

[1] Lin Jinhong. (2012) Clinical Analysis of Electroresection in the Treatment of Benign Prostatic Hyperplasia[J]. Medical Theory & Practice, 25(2), 173~174.
[2] Mahon JT, Welliver C. (2020 Nov 19) National Trends in the Management of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. Curr Urol Rep, 21(12), 63. 
[3] Liu Yang, An Liwen. (2006) Research Progress and Status Quo of Traditional Chinese Medicine in the Treatment of Benign Prostatic Hyperplasia [J]. Chinese Journal of Andrology, 6, 71-72.
[4] Meng Fanchao, Li Haisong, Zhao Qi, et al. (2021) Observation on the Efficacy of Lingze Tablets in the Treatment of Benign Prostatic Hyperplasia in the Real World[J]. Chinese Journal of Andrology, 35(04), 40-44.
[5] Dong Xing, Chen Jifeng. (2021) Research Progress in Diagnosis and Treatment of Prostatic Hyperplasia[J]. Chinese Journal of Contemporary Medicine, 28(23), 45-48.
[6] Lu Yang, Liang Wei, Ding Quanming et al. (2012) Clinical Analysis of α1 Receptor Blocker Therapy after Prostatic Hyperplasia[J]. Shanxi Journal of Medicine, 41(9), 908-909.
[7] Zeng Shun, Huang Jiangbo, Chen Yingzhu, Luo Huan, et al. (2018) Clinical Application of Acupoint Application in Postoperative Prostatic Hyperplasia [J]. Massage and Rehabilitation Medicine, 9(8), 70-71.
[8] Zheng Yanjun, Liu Shushuo. (2012) Efficacy of huangʼe Tongguan Capsule in the Treatment of Benign Prostatic Hyperplasia [J]. Zhejiang Journal of Integrated Traditional and Western Medicine, 22(11), 892-893.
[9] Zhang Wujie, Zhang Xiaolei, Lv Xiaojun. (2009) Treatment and Cause Analysis of Common Complications after Prostatic Hyperplasia. Jilin Medicine, 17, 1936-1937.
[10] Lai Haibiao. (2008) Chinese Patent Medicine in the Treatment of Benign Prostatic Hyperplasia[A]. Chinese Association of Integrative Medicine, 170-173.
[11] Geng Qiang. (2018) Chinese Expert Consensus on the Clinical Application of huangʼe Capsule in Benign Prostatic Hyperplasia [J]. Chinese Journal of Andrology, 24(10), 945-948.
[12] Lv Zhizhen, Li Yinzeng, Han Qide, et al. (2001) Antagonistic Effect of Anti-Seizure on α1-adrenergic Receptors [J]. Journal of Peking University (Health Sciences), 2, 157-159.
[13] Jia Jinming, Cui Yugui, Zhang Guiyuan, et al. (1997) Traditional Chinese Medicine to Eliminate the Seizure of Anti-Seizure Prostate Tissue in Canine T.E 2. DHT. Effect of AR and 5α-reductase. Modern Journal of Urology, 2(1), 45-49.

Sponsors, Associates, and Links

---

• Journal of Neurobiology and Genetics
  
  
• Medical Imaging and Nuclear Medicine
  
  
• Bacterial Genetics and Ecology
  
  
• Transactions on Cancer
  
  
• Journal of Biophysics and Ecology
  
  
• Journal of Animal Science and Veterinary
  
  
• Academic Journal of Biochemistry and Molecular Biology
  
  
• Transactions on Cell and Developmental Biology
  
  
• Rehabilitation Engineering & Assistive Technology
  
  
• Orthopaedics and Sports Medicine
  
  
• Hematology and Stem Cell
  
  
• Journal of Intelligent Informatics and Biomedical Engineering
  
  
• MEDS Basic Medicine
  
  
• MEDS Stomatology
  
  
• MEDS Public Health and Preventive Medicine
  
  
• MEDS Chinese Medicine
  
  
• Journal of Enzyme Engineering
  
  
• Advances in Industrial Pharmacy and Pharmaceutical Sciences
  
  
• Bacteriology and Microbiology
  
  
• Advances in Physiology and Pathophysiology
  
  
• Journal of Vision and Ophthalmology
  
  
• Frontiers of Obstetrics and Gynecology
  
  
• Digestive Disease and Diabetes
  
  
• Advances in Immunology and Vaccines
  
  
• Nanomedicine and Drug Delivery
  
  
• Cardiology and Vascular System
  
  
• Pediatrics and Child Health
  
  
• Journal of Reproductive Medicine and Contraception
  
  
• Journal of Respiratory and Lung Disease
  
  
• Journal of Bioinformatics and Biomedicine